Last Updated
Case Status
Pending
In the Matter of Aurobindo Pharma LTD, a corporation; Aurobindo USA Inc., a corporation; and Lannett Company, Inc., a corporation.
FTC Matter/File Number
251 0096
Docket Number
C-4834
Enforcement Type
Part 2 Consents
Case Summary
The FTC is requiring Aurobindo Pharma Limited to divest four different generic drug products to complete its $250 million acquisition of Lannett Company Inc.